Mirae Asset Mutual Fund Trims Stake in Syngene International

Mirae Asset Mutual Fund sold some of its shares in Syngene International.

This reduced their ownership by a small amount, about 0.16%.

The fund still owns a significant part of the company, approximately 2.95% of the shares.

Syngene International provides services for drug discovery and manufacturing.

The company's profits and revenue have increased.

Syngene's shares have decreased by 32% since December but are still well above their March 2020 low.